Hiroshi Mohri

Also affiliated with Columbia University

EngineeringImmunology and MicrobiologyMaterials ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking”.

Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.08.536123

N/A

0.693DataRank · unranked

12 citations

Ryan G. Casner, Yicheng Guo, Qian Wang, Sho Iketani, Jasper Fuk‐Woo Chan +15 more

SARS-CoV-2 RNA Shedding in Semen and Oligozoospermia of Patient with Severe Coronavirus Disease 11 Weeks after Infection

Emerging infectious diseases(2021)10.3201/eid2801.211521

N/A

0DataRank · unranked

21 citations

Joseph P. Alukal, Alexander M. Chong, Lihong Liu, Anyelina Cantos, Jayesh Shah +8 more

Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient

American Journal of Transplantation(2021)10.1111/ajt.16837

N/A

0DataRank · unranked

10 citations

Michelle Chang, Medini K. Annavajhala, Hiroshi Mohri, Lihong Liu, Jayesh Shah +12 more

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

Nature(2022)10.1038/s41586-022-05053-w

N/A

0DataRank · unranked

845 citations

Yicheng Guo, Sho Iketani, Manoj S. Nair, Zhiteng Li, Hiroshi Mohri +15 more

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

Nature Communications(2022)10.1038/s41467-022-29413-2

N/A

0DataRank · unranked

96 citations

Sho Iketani, Arie Zask, Nisha Khanizeman, Eva Bednářová, F. Forouhar +27 more

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.26.493517

N/A

0DataRank · unranked

41 citations

Yicheng Guo, Sho Iketani, Manoj S. Nair, Zhiteng Li, Hiroshi Mohri +15 more

SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasion

Research Square(2022)10.21203/rs.3.rs-1696532/v1

N/A

0DataRank · unranked

12 citations

Qian Wang, Yicheng Guo, Sho Iketani, Zhiteng Li, Hiroshi Mohri +13 more

Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking

Immunity(2023)10.1016/j.immuni.2023.09.003

N/A

0DataRank · unranked

32 citations

Ryan G. Casner, Yicheng Guo, Qian Wang, Sho Iketani, Jasper Fuk‐Woo Chan +15 more

Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2

Emerging Microbes & Infections(2023)10.1080/22221751.2023.2210237

N/A

0DataRank · unranked

3 citations

Andre Yanchen Yeh, Yicheng Guo, Hiroshi Mohri, Jian Yu, David D. Ho +2 more

Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York

Nature(2021)10.1038/s41586-021-03908-2

N/A

0DataRank · unranked

140 citations

Hiroshi Mohri, Pengfei Wang, Manoj S. Nair, Jason Zucker, Zizhang Sheng +8 more

Impaired potency of neutralizing antibodies against cell-cell fusion mediated by SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.09.531948

N/A

0DataRank · unranked

0 citations

Andre Yanchen Yeh, Yicheng Guo, Hiroshi Mohri, Jian Yu, David D. Ho +2 more